1. Liao, Yunfei, Luo, Zaili, Lin, Yifeng, Zhou, Wenhao, Lu, Q Richard. 2022. PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism. In Cell death & disease, 13, 943. doi:10.1038/s41419-022-05389-1. https://pubmed.ncbi.nlm.nih.gov/36351894/
2. Verma, Mamta, Khan, Mohd Imran K, Kadumuri, Rajashekar Varma, Chavali, Sreenivas, Dhayalan, Arunkumar. 2021. PRMT3 interacts with ALDH1A1 and regulates gene-expression by inhibiting retinoic acid signaling. In Communications biology, 4, 109. doi:10.1038/s42003-020-01644-3. https://pubmed.ncbi.nlm.nih.gov/33495566/
3. Zou, Wanyi, Li, Mengna, Wan, Shili, Li, Jia, Zhou, Bing. 2024. Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2405963. doi:10.1002/advs.202405963. https://pubmed.ncbi.nlm.nih.gov/39120042/
4. Zhang, Wuwen, Li, Shifeng, Li, Kai, Wu, Yuanyuan, Yan, Hua. 2025. PRMT3 gene expression and methylation levels in arrested embryos: Implications for developmental arrest defects. In Developmental biology, 520, 264-271. doi:10.1016/j.ydbio.2025.01.018. https://pubmed.ncbi.nlm.nih.gov/39892499/
5. Huh, K H, Cho, Y, Kim, B S, Kim, M S, Kim, Y S. . PRMT3: new binding molecule to RhoGDI-α during mycophenolic acid-induced β-cell death. In Transplantation proceedings, 46, 1229-32. doi:10.1016/j.transproceed.2013.12.016. https://pubmed.ncbi.nlm.nih.gov/24815167/
6. Min, Zhang, Xiaomeng, Liu, Zheng, Li, Ping, Zhang, Yongsheng, Zhou. 2019. Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648. In Cell death & disease, 10, 581. doi:10.1038/s41419-019-1815-7. https://pubmed.ncbi.nlm.nih.gov/31378783/
7. Kim, Dong-il, Park, Min-jung, Lim, Seul-ki, Lim, Jae-hyang, Park, Soo-hyun. 2014. PRMT3 regulates hepatic lipogenesis through direct interaction with LXRα. In Diabetes, 64, 60-71. doi:10.2337/db13-1394. https://pubmed.ncbi.nlm.nih.gov/25187371/
智鼠故事 
